In vitro activity of rifampin-minocyclin coating to Candida albicans.
Schierholz
J M
JM
Pulverer
G
G
Bach
A
A
Wachol-Drebeck
Z
Z
D000900:Anti-Bacterial Agents; D002176:Candida albicans / Q000187:drug effects*; D002408:Catheters, Indwelling / Q000382:microbiology*; D020099:Coated Materials, Biocompatible; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004866:Equipment Contamination / Q000517:prevention & control*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008911:Minocycline; D019384:Nucleic Acid Synthesis Inhibitors; D012293:Rifampin
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible; D019384:Nucleic Acid Synthesis Inhibitors; D008911:Minocycline; D012293:Rifampin